Characteristics of skeletal muscle in mdx mutant mice.
暂无分享,去创建一个
S. de la Porte | J Koenig | S De la Porte | S Morin | J. Koenig | S. Morin | S. Morin | Jeanine Koenig
[1] L. Kunkel,et al. Subcellular fractionation of dystrophin to the triads of skeletal muscle , 1987, Nature.
[2] D. Shotton,et al. Muscular dystrophy in the mdx mouse: Histopathology of the soleus and extensor digitorum longus muscles , 1987, Journal of the Neurological Sciences.
[3] C. Carlson,et al. Single channel evidence for a cytoskeletal defect involving acetylcholine receptors and calcium influx in cultured dystrophic (MDX) myotubes , 1996, Muscle & nerve.
[4] C. Franke,et al. Acetylcholine activates two types of ion channels in sarcolemma from adult muscular dystrophic (mdx) mice , 1992, Neuroscience Letters.
[5] M. Perricaudet,et al. Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[6] F. Muntoni,et al. Dystrophin immunoreactivity in normal and duchenne human fetal neurons in culture , 1992, Journal of neuroscience research.
[7] Richard O. Hynes,et al. Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.
[8] T. Bertorini,et al. Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy , 1990, The Lancet.
[9] U. Nudel,et al. Expression of the Duchenne muscular dystrophy gene products in embryonic stem cells and their differentiated derivatives. , 1992, The Journal of biological chemistry.
[10] Simon C Watkins,et al. Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons , 1990, Nature.
[11] Kenji Nakamura,et al. Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy. , 1997, Biochemical and biophysical research communications.
[12] B. Lucas-Héron,et al. Mdx mouse skeletal muscle: Could a mitochondrial factor be responsible for the absence of progressive necrosis? , 1994, Neuroscience Letters.
[13] T. Quirico-Santos,et al. Increased deposition of extracellular matrix components in the thymus gland of MDX mouse: correlation with the muscular lesion. , 1995 .
[14] M. Takemitsu,et al. Dystrophin-related protein in the fetal and denervated skeletal muscles of normal and mdx mice. , 1991, Biochemical and biophysical research communications.
[15] A. Moorman,et al. Different localization of dystrophin in developing and adult human skeletal muscle , 1991, Muscle & nerve.
[16] S. Carpenter,et al. Small‐caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy , 1988, Muscle & nerve.
[17] M. Ecob-Prince,et al. Localization of dystrophin in cultures of human muscle , 1989, Muscle & nerve.
[18] S. Carbonetto,et al. Dystroglycan-α, a dystrophin-associated glycoprotein, is a functional agrin receptor , 1994, Cell.
[19] K. Inui,et al. Gene therapy in Duchenne muscular dystrophy , 1996, Brain and Development.
[20] K. Davies,et al. Primary structure of dystrophin-related protein , 1992, Nature.
[21] C. Franke,et al. The coexistence of embryonic and adult acetylcholine receptors in sarcolemma of mdx dystrophic mouse muscle: An effect of regeneration or muscular dystrophy? , 1994, Neuroscience Letters.
[22] E. Bonilla,et al. Immunocytochemical study of dystrophin at the myotendinous junction , 1990, Muscle & nerve.
[23] B. Olwin,et al. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation , 1991, Science.
[24] Hanns Lochmüller,et al. Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. , 1996, Human gene therapy.
[25] P. Rogers,et al. Quantitative analysis of dystrophin in fast‐ and slow‐twitch mammalian skeletal muscle , 1992, FEBS letters.
[26] R. Betto,et al. Interaction of dystrophin with cytoskeletal proteins: binding to talin and actin. , 1993, Biochemical and biophysical research communications.
[27] P. Bohlen,et al. Isolation and amino-terminal sequence of a novel cellular growth inhibitor (inhibitory diffusible factor 45) secreted by 3T3 fibroblasts. , 1989, The Journal of biological chemistry.
[28] G. Comi,et al. Appearance and localization of dystrophin in normal human fetal muscle , 1991, International Journal of Developmental Neuroscience.
[29] F. Beltrame,et al. Dystrophin at the plasma membrane of human muscle fibers shows a costameric localization , 1992, Neuromuscular Disorders.
[30] S. Shafiq,et al. In Situ Hybridization Analysis for Expression of Myogenic Regulatory Factors in Regenerating Muscle of mdx Mouse , 1996, Journal of neuropathology and experimental neurology.
[31] Eric P. Hoffman,et al. Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.
[32] K. Aldape,et al. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy , 1995, Cell.
[33] M. Takemitsu,et al. Immunoblot analysis of dystrophin-related protein (DRP). , 1993, Biochimica et biophysica acta.
[34] A. Sonnenberg. Integrins and their ligands. , 1993, Current topics in microbiology and immunology.
[35] G. Dickson,et al. Mini-dystrophin gene transfer in mdx4cv diaphragm muscle fibers increases sarcolemmal stability , 1997, Gene Therapy.
[36] K. Campbell,et al. Restoration of dystrophin‐associated proteins in skeletal muscle of mdx mice transgenic for dystrophin gene , 1993, FEBS letters.
[37] A. Moir,et al. Binding sites involved in the interaction of actin with the N‐terminal region of dystrophin , 1992, FEBS letters.
[38] G. Piluso,et al. The fourth component of the sarcoglycan complex , 1997, FEBS letters.
[39] R. Gossrau,et al. Nitric oxide synthase I (NOS-I) is deficient in the sarcolemma of striated muscle fibers in patients with Duchenne muscular dystrophy, suggesting an association with dystrophin. , 1996, Acta histochemica.
[40] K. Campbell,et al. Clustering and immobilization of acetylcholine receptors by the 43-kD protein: a possible role for dystrophin-related protein , 1993, The Journal of cell biology.
[41] J. Huard,et al. Localization of dystrophin in the Purkinje cells of normal mice , 1992, Neuroscience Letters.
[42] P. Schofield,et al. Programmed cell death in dystrophic (mdx) muscle is inhibited by IGF-II. , 1995, Cell death and differentiation.
[43] S. Burden,et al. Dystrophin is a component of the subsynaptic membrane , 1991, The Journal of cell biology.
[44] J. Bobet,et al. Contractile properties of myocardium are altered in dystrophin-deficient mdx mice , 1996, Journal of the Neurological Sciences.
[45] B. Gillet,et al. In vivo 2D 1H NMR of mdx mouse muscle and myoblast cells during fusion: Evidence for a characteristic signal of long chain fatty acids , 1993, Neuromuscular Disorders.
[46] J. Chelly,et al. La myopathie de Duchenne, du gène DMD à la dystrophine , 1988 .
[47] A. Sébille,et al. mdx mice show progressive weakness and muscle deterioration with age , 1995, Journal of the Neurological Sciences.
[48] R. Strohman,et al. Fiber regeneration is not persistent in dystrophic (MDX) mouse skeletal muscle. , 1991, Developmental biology.
[49] H. Schmalbruch,et al. Antidystrophin stains triadic junctions in regenerating rat muscles , 1991, Muscle & nerve.
[50] R. Roy,et al. Quantification of normal dystrophin mRNA following myoblast transplantation in mdx mice , 1995, Muscle & nerve.
[51] M. Way,et al. Expression of the N‐terminal domain of dystrophin in E. coli and demonstration of binding to F‐actin , 1992, FEBS letters.
[52] D. Clemmons,et al. Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I , 1993, The Journal of cell biology.
[53] J. Gillis,et al. Specific increase of genetic expression of parvalbumin in fast skeletal muscles of mdx mice , 1993, FEBS letters.
[54] H. Eppenberger,et al. Muscle morphogenesis: Evidence for an organizing function of exogenous fibronectin. , 1981, Developmental biology.
[55] K. Davies,et al. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice , 1998, Nature Genetics.
[56] A. Engel,et al. Neuromuscular transmission in the mdx mouse , 1990, Muscle & nerve.
[57] M. Uchino,et al. Dystrophin: Localization and presumed function , 1991, Muscle & nerve.
[58] R. Edwards,et al. Protein turnover is elevated in muscle of mdx mice in vivo. , 1990, The Biochemical journal.
[59] P. Strata,et al. Increase of B-50/GAP-43 immunoreactivity in uninjured muscle nerves of mdx mice , 1996, Neuroscience.
[60] M. Matsuo,et al. Duchenne/Becker muscular dystrophy: From molecular diagnosis to gene therapy , 1996, Brain and Development.
[61] M. E. Kargacin,et al. The sarcoplasmic reticulum calcium pump is functionally altered in dystrophic muscle. , 1996, Biochimica et biophysica acta.
[62] E. Kardami,et al. Distinctive patterns of basic fibroblast growth factor (bFGF) distribution in degenerating and regenerating areas of dystrophic (mdx) striated muscles. , 1991, Developmental biology.
[63] A. Monaco,et al. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene , 1986, Nature.
[64] H. Erickson,et al. Tenascin‐C expression in dystrophin‐related muscular dystrophy , 1996, Muscle & nerve.
[65] T. Tsukahara,et al. Antibody against the C-terminal portion of dystrophin crossreacts with the 400 kDa protein in the pia mater of dystrophin-deficient mdx mouse brain. , 1990, Journal of biochemistry.
[66] J. Gillis,et al. Membrane abnormalities and Ca homeostasis in muscles of the mdx mouse, an animal model of the Duchenne muscular dystrophy: a review. , 1996, Acta physiologica Scandinavica.
[67] K. Campbell,et al. Association of dystrophin and an integral membrane glycoprotein , 1989, Nature.
[68] G. Pari,et al. Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice. , 1996, Gene therapy.
[69] Simon C Watkins,et al. Interaction of chromosome-6-encoded dystrophin related protein with the extracellular matrix. , 1995, Journal of cell science.
[70] K. Campbell,et al. Animal Models for Muscular Dystrophy Show Different Patterns of Sarcolemmal Disruption , 1997, The Journal of cell biology.
[71] G. Goldspink,et al. Accumulation of collagen and altered fiber‐type ratios as indicators of abnormal muscle gene expression in the mdx dystrophic mouse , 1989, Muscle & nerve.
[72] A. Parent,et al. Dystrophin-like immunoreactivity in monkey and human brain areas involved in learning and motor functions , 1992, Neuroscience Letters.
[73] K. Moore,et al. X chromosome-linked muscular dystrophy (mdx) in the mouse. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[74] A. Monaco,et al. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein , 1988, Cell.
[75] J. Ervasti,et al. Membrane organization of the dystrophin-glycoprotein complex , 1991, Cell.
[76] K. Campbell,et al. Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice , 1991, The Journal of cell biology.
[77] J. Fedrick. Anencephalus and the Local Water Supply , 1970, Nature.
[78] D. Branton,et al. Sequence similarity of the amino-terminal domain of Drosophila beta spectrin to alpha actinin and dystrophin , 1989, The Journal of cell biology.
[79] J. Lefaucheur,et al. Mouse muscle regeneration: an in vivo 2D 1H magnetic resonance spectroscopy (MRS) study , 1998, FEBS letters.
[80] M. G. Cusella De Angelis,et al. High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies. , 1998, The Journal of clinical investigation.
[81] A. Moorman,et al. Monoclonal antibody evidence for structural similarities between the central rod regions of actinin and dystrophin , 1990, FEBS letters.
[82] S. Head. Membrane potential, resting calcium and calcium transients in isolated muscle fibres from normal and dystrophic mice. , 1993, The Journal of physiology.
[83] F. Muntoni,et al. Muscular weakness in the mdx mouse , 1993, Journal of the Neurological Sciences.
[84] M. Koenig,et al. Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals , 1987, Cell.
[85] J. Ervasti,et al. Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle , 1991, Neuron.
[86] M. Lyon,et al. The mapping of a cDNA from the human X-linked Duchenne muscular dystrophy gene to the mouse X chromosome , 1987, Nature.
[87] B. Lucas-Héron,et al. Age-related calmitine distribution in mitochondria of normal and mdx mouse skeletal muscle , 1990, Journal of the Neurological Sciences.
[88] O. Ibraghimov-Beskrovnaya,et al. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix , 1992, Nature.
[89] P. Lai,et al. Dystrophin function: calcium-related rather than mechanical , 1990, The Lancet.
[90] H. Sweeney,et al. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[91] Doris M. Miller,et al. Muscular dystrophy in a litter of golden retriever dogs , 1988, Muscle & nerve.
[92] R. Heilig,et al. Isolated dystrophin molecules as seen by electron microscopy. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[93] K. Davies,et al. Tissue distribution of the dystrophin-related gene product and expression in the mdx and dy mouse. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[94] M. Grounds,et al. Rapid death of injected myoblasts in myoblast transfer therapy , 1996, Muscle & nerve.
[95] J. Sanes,et al. Distribution and Function of Laminins in the Neuromuscular System of Developing, Adult, and Mutant Mice , 1997, The Journal of cell biology.
[96] E. Ozawa,et al. Expression of dystrophin mRNA and the protein in the developing rat heart. , 1990, Biochemical and biophysical research communications.
[97] R. Bartlett,et al. An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. , 1992, Genomics.
[98] R. Vracko,et al. BASAL LAMINA: THE SCAFFOLD FOR ORDERLY CELL REPLACEMENT , 1972, The Journal of cell biology.
[99] Y. Courtois,et al. Accumulation of NO synthase (type‐I) at the neuromuscular junctions in adult mice , 1996, Neuroreport.
[100] K. Davies,et al. Localization and Quantitation of the Chromosome 6-Encoded Dystrophin-Related Protein in Normal and Pathological Human Muscle , 1993, Journal of neuropathology and experimental neurology.
[101] B. Wolthers. Kinetics of inhibition of papain by TLCK and TPCK in the presence of BAEE as substrate , 1969, FEBS Letters.
[102] E. Hoffman,et al. Molecular biology of Duchenne muscular dystrophy , 1988, Trends in Neurosciences.
[103] J. Vilquin,et al. Pretreatment of myoblast cultures with basic fibroblast growth factor increases the efficacy of their transplantation in mdx mice , 1995, Muscle & nerve.
[104] E A Barnard,et al. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. , 1989, Science.
[105] J. D. Porter,et al. The sparing of extraocular muscle in dystrophinopathy is lost in mice lacking utrophin and dystrophin. , 1998, Journal of cell science.
[106] J. Bobet,et al. Force and stiffness of old dystrophic (mdx) mouse skeletal muscles , 1998, Muscle & nerve.
[107] U J McMahan,et al. Reinnervation of muscle fiber basal lamina after removal of myofibers. Differentiation of regenerating axons at original synaptic sites , 1978, The Journal of cell biology.
[108] J. Dunn,et al. Sodium is elevated in mdx muscles: Ionic interactions in dystrophic cells , 1993, Journal of the Neurological Sciences.
[109] J. Stull,et al. Sparing of mdx extraocular muscles from dystrophic pathology is not attributable to normalized concentration or distribution of neuronal nitric oxide synthase , 1998, Neuromuscular Disorders.
[110] M. W. Marshall,et al. Excitation contraction coupling in normal and mdx mice , 1990, Muscle & nerve.
[111] I. Kinoshita,et al. Successful histocompatible myoblast transplantation in dystrophin- deficient mdx mouse despite the production of antibodies against dystrophin , 1995, The Journal of cell biology.
[112] R. Steinhardt,et al. Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice , 1988, Nature.
[113] K. Campbell,et al. Utrophin to the rescue , 1996, Nature.
[114] J. Tremblay,et al. Evidence of mdx mouse skeletal muscle fragility in vivo by eccentric running exercise , 1998, Muscle & nerve.
[115] A J Bailey,et al. The location of three collagen types in skeletal muscle , 1977, FEBS letters.
[116] J. Tidball,et al. Apoptosis precedes necrosis of dystrophin-deficient muscle. , 1995, Journal of cell science.
[117] R. Steinhardt,et al. A critical evaluation of resting intracellular free calcium regulation in dystrophic mdx muscle. , 1996, The American journal of physiology.
[118] K. Davies,et al. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene , 1996, Nature.
[119] J. Léger,et al. A homologue of dystrophin is expressed at the neuromuscular junctions of normal individuals and DMD patients, and of normal and mdx mice Immunological evidence , 1991, FEBS letters.
[120] Simon C Watkins,et al. Somatic reversion/suppression of the mouse mdx phenotype in vivo , 1990, Journal of the Neurological Sciences.
[121] Hanns Lochmüller,et al. Impairment of force generation after adenovirus-mediated gene transfer to muscle is alleviated by adenoviral gene inactivation and host CD8+ T cell deficiency. , 1996, Human gene therapy.
[122] M. Araki,et al. Increased leakage of calcium ion from the sarcoplasmic reticulum of the mdx mouse , 1992, Journal of the Neurological Sciences.
[123] J. Valmier,et al. Early postnatal muscle contractile activity regulates the carbonic anhydrase phenotype of proprioceptive neurons in young and mature mice: Evidence for a critical period in development , 1996, Neuroscience.
[124] P. Avner,et al. Localization of the region homologous to the Duchenne muscular dystrophy locus on the mouse X chromosome , 1987, Nature.
[125] J. Stamler,et al. Nitric oxide in skeletal muscle , 1994, Nature.
[126] J. Sanes,et al. Subtle Neuromuscular Defects in Utrophin-deficient Mice , 1997, The Journal of cell biology.
[127] T. Miike,et al. Dystrophin isoforms and/or cross-reactive proteins on neurons and glial cells in control and mdx central nervous systems , 1992, Journal of the Neurological Sciences.
[128] D. Clemmons,et al. Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. , 1992, The Journal of biological chemistry.
[129] L. Metzinger,et al. Modulation by prednisolone of calcium handling in skeletal muscle cells , 1995, British Journal of Pharmacology.
[130] J. Nalbantoglu,et al. Study of adenovirus-mediated dystrophin minigene transfer to skeletal muscle by combined microscopic display of adenoviral DNA and dystrophin. , 1997, Human gene therapy.
[131] K. Arahata,et al. Dystrophin and the membranehypothesis of muscular dystrophy , 1989 .
[132] M. Grounds,et al. A potential alternative strategy for myoblast transfer therapy: the use of sliced muscle grafts. , 1996, Cell transplantation.
[133] D. Blake,et al. Utrophin: A Structural and Functional Comparison to Dystrophin , 1996, Brain pathology.
[134] C. Blat,et al. Inhibitory diffusible factor 45 bifunctional activity. As a cell growth inhibitor and as an insulin-like growth factor I-binding protein. , 1989, The Journal of biological chemistry.
[135] P. Briand,et al. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice , 1993, Nature.
[136] Y. Matsuda,et al. Topographic comparison of subneural apparatuses at neuromuscular junctions in normal and dystrophic (mdx) mice: a scanning electron microscope study. , 1997, Journal of electron microscopy.
[137] L. Kunkel,et al. The molecular and biochemical basis of Duchenne muscular dystrophy. , 1992, Trends in biochemical sciences.
[138] K. Ohlendieck,et al. Dystrophin constitutes 5% of membrane cytoskeleton in skeletal muscle , 1991, FEBS letters.
[139] L. Oliver,et al. Acidic fibroblast growth factor (aFGF) in developing normal and dystrophic (mdx) mouse muscles. Distribution in degenerating and regenerating mdx myofibres. , 1992, Growth factors.
[140] J. Lefaucheur,et al. Basic fibroblast growth factor promotes in vivo muscle regeneration in murine muscular dystrophy , 1995, Neuroscience Letters.
[141] M. Jackson,et al. Age‐related changes in muscle calcium content in dystrophin‐deficient mdx mice , 1997, Muscle & nerve.
[142] F. Bezanilla,et al. A patch‐clamp study of delayed rectifier currents in skeletal muscle of control and mdx mice. , 1996, The Journal of physiology.
[143] T. Miike,et al. Dystrophin and dystrophin‐related protein in the brains of normal and mdx mice , 1994, Muscle & nerve.
[144] J. Kornegay,et al. Canine X-linked muscular dystrophy as an animal model of Duchenne muscular dystrophy: a review. , 1992, American journal of medical genetics.
[145] J. Lansman,et al. Developmental regulation of mechanosensitive calcium channels in skeletal muscle from normal and mdx mice , 1991, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[146] Takayoshi Kobayashi,et al. Developmental study of the expression of dystrophin in cultured human muscle aneurally and innervated with fetal rat spinal cord , 1991, Brain Research.
[147] H. Sweeney,et al. Adaptations in myosin heavy chain expression and contractile function in dystrophic mouse diaphragm. , 1993, The American journal of physiology.
[148] Simon C Watkins,et al. Immunoelectron microscopic localization of dystrophin in myofibres , 1988, Nature.
[149] Y. Pouliot,et al. Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. , 1989, The American journal of pathology.
[150] T. Gasser,et al. In Vitro Studies , 1992 .
[151] J. Huard,et al. A light and electron microscopic study of dystrophin localization at the mouse neuromuscular junction , 1992, Synapse.
[152] K. Beam. Localizing the gene product , 1988, Nature.
[153] C. Tiger,et al. Absence of laminin α1 chain in the skeletal muscle of dystrophic dy/dy mice , 1997 .
[154] P. Distefano,et al. Agrin Acts via a MuSK Receptor Complex , 1996, Cell.
[155] G. Vrbóva,et al. Muscle development in mdx mutant mice , 1984, Muscle & nerve.
[156] R. Massa,et al. Glucocorticoids and immunosup pressants do not change the prevalence of necrosis and regeneration in mdx skeletal muscles , 1991, Muscle & nerve.
[157] K. Campbell,et al. Sarcospan, the 25-kDa Transmembrane Component of the Dystrophin-Glycoprotein Complex* , 1997, The Journal of Biological Chemistry.
[158] F. Walsh,et al. Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo. , 1993, Human molecular genetics.
[159] D. Watt,et al. Dermal fibroblasts convert to a myogenic lineage in mdx mouse muscle. , 1995, Journal of cell science.
[160] J. Mandel. The gene and its product , 1989, Nature.
[161] E. Engvall,et al. Merosin and laminin in myogenesis; specific requirement for merosin in myotube stability and survival , 1996, The Journal of cell biology.
[162] H. Mizusawa,et al. A case of cluster headache associated with mitochondrial DNA deletions , 1997, Muscle & nerve.
[163] K. Campbell,et al. Forced expression of dystrophin deletion constructs reveals structure- function correlations , 1996, The Journal of cell biology.
[164] J. Gillis,et al. Critical evaluation of cytosolic calcium determination in resting muscle fibres from normal and dystrophic (mdx) mice. , 1993, Cell calcium.
[165] D. Bulman,et al. Age-Related Conversion of Dystrophin-Negative to -Positive Fiber Segments of Skeletal but not Cardiac Muscle Fibers in Heterozygote mdx Mice , 1990, Journal of neuropathology and experimental neurology.
[166] T. Partridge,et al. Aging normal and dystrophic mouse muscle: Analysis of myogenicity in cultures of living single fibers , 1998, Muscle & nerve.
[167] Differential glucocorticoid effects on the fusion of Duchenne/Becker and control muscle cultures , 1992, Neurology.
[168] T. Tsukahara,et al. Laminin in Animal Models for Muscular Dystrophy Defect of Laminin M in Skeletal and Cardiac Muscles and Peripheral Nerve of the Homozygous Dystrophic dy/dy Mice. , 1993 .
[169] L. Duchen,et al. The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates. , 1987, Brain : a journal of neurology.
[170] J. Léger,et al. Prednisolone enhances myogenesis and dystrophin‐related protein in skeletal muscle cell cultures from mdx mouse , 1993, Journal of neuroscience research.
[171] J. Chatel,et al. Molecular forms of acetylcholinesterase in dystrophic (mdx) mouse tissues , 1992, Neuromuscular Disorders.
[172] J. Ervasti,et al. Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle , 1992, Nature.
[173] F. Walsh,et al. Tissue-specific isoforms of dystrophin , 1989, Trends in Neurosciences.
[174] R. Gibbs,et al. Expression of the murine Duchenne muscular dystrophy gene in muscle and brain. , 1988, Science.
[175] W. Denetclaw,et al. Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin. , 1990, Science.
[176] H. Tsukagoshi,et al. A developmental change in the content of parvalbumin in normal and dystrophic mouse (mdx) muscle , 1990, Journal of the Neurological Sciences.
[177] R. R. Rice,et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. , 1995, The New England journal of medicine.
[178] S. Kochanek,et al. Persistence in muscle of an adenoviral vector that lacks all viral genes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[179] L. Metzinger,et al. α-Methylprednisolone promotes skeletal myogenesis in dystrophin-deficient and control mouse cultures , 1993, Neuroscience Letters.
[180] J. Kornegay,et al. Immunohistochemical detection of neural cell adhesion molecule and laminin in X-linked dystrophic dogs and mdx mice. , 1994, Journal of comparative pathology.
[181] N. Bleehen,et al. Diminished Expression of Insulin-like Growth Factor (IGF) Binding Protein-5 and Activation of IGF-I-mediated Autocrine Growth in Simian Virus 40-transformed Human Fibroblasts (*) , 1995, The Journal of Biological Chemistry.
[182] E. Hoffman,et al. A role for mast cells in the progression of Duchenne muscular dystrophy? Correlations in dystrophin-deficient humans, dogs, and mice , 1994, Journal of the Neurological Sciences.
[183] L. McIntosh,et al. Deflazacort but not prednisone improves both muscle repair and fiber growth in diaphragm and limb muscle in vivo in the mdx dystrophic mouse , 1996, Muscle & nerve.
[184] L. Kunkel,et al. Cell and fiber type distribution of dystrophin , 1988, Neuron.
[185] G. Robertson,et al. Local Transcriptional Control of Utrophin Expression at the Neuromuscular Synapse* , 1997, The Journal of Biological Chemistry.
[186] S. Brown,et al. Dystrophin as a mechanochemical transducer in skeletal muscle. , 1993, BioEssays : news and reviews in molecular, cellular and developmental biology.
[187] M. Grounds,et al. Age-related changes in replication of myogenic cells in mdx mice: Quantitative autoradiographic studies , 1993, Journal of the Neurological Sciences.
[188] J. Tidball,et al. Dystrophin is required for normal thin filament-membrane associations at myotendinous junctions. , 1991, The American journal of pathology.
[189] E. Van Obberghen,et al. Expression of the glucose transporter GLUT4 in the muscular dystrophic mdx mouse. , 1993, Biochemical Journal.
[190] B. Lu,et al. Nitric oxide mediates activity-dependent synaptic suppression at developing neuromuscular synapses , 1995, Nature.
[191] T. Partridge,et al. THE mdx MOUSE SKELETAL MUSCLE MYOPATHY: I. A HISTOLOGICAL, MORPHOMETRIC AND BIOCHEMICAL INVESTIGATION , 1988, Neuropathology and applied neurobiology.
[192] M. Salpeter,et al. Acetylcholine Receptors in Innervated Muscles of Dystrophicmdx Mice Degrade as after Denervation , 1997, The Journal of Neuroscience.
[193] C. C. Clark,et al. Biochemistry and metabolism of basement membranes. , 1979, International review of cytology.
[194] L. Kunkel,et al. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts , 1989, Nature.
[195] R. Rosenberg,et al. Inhibition of Rat Arterial Smooth Muscle Cell Proliferation by Heparin: II. In Vitro Studies , 1980, Circulation research.
[196] R. Heilig,et al. The chicken dystrophin cDNA: striking conservation of the C‐terminal coding and 3′ untranslated regions between man and chicken. , 1988, The EMBO journal.
[197] T. Miike,et al. Possible systemic smooth muscle layer dysfunction due to a deficiency of dystrophin in Duchenne muscular dystrophy , 1989, Journal of the Neurological Sciences.
[198] J. Ervasti,et al. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle , 1990, Nature.
[199] D. Bredt,et al. Interaction of Nitric Oxide Synthase with the Postsynaptic Density Protein PSD-95 and α1-Syntrophin Mediated by PDZ Domains , 1996, Cell.
[200] C. Blat,et al. Modulation by the src oncogene of the effect of inhibitory diffusible factor IDF45 , 1987, Journal of cellular physiology.
[201] Hanns Lochmüller,et al. High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: prolongation of expression with immunosuppression. , 1998, Human gene therapy.
[202] J. Champagnat,et al. 1H COSY spectra of superfused brain slices of rat: Ex vivo direct assignment of resonances , 1989, Magnetic resonance in medicine.
[203] G. E. Jones,et al. Conversion of dermal fibroblasts to a myogenic lineage is induced by a soluble factor derived from myoblasts , 1996, Journal of cellular biochemistry.
[204] R. McCARTER,et al. Does muscular dystrophy affect metabolic rate? A study in mdx mice , 1994, Journal of the Neurological Sciences.
[205] T. Mitsui,et al. Induction of dystrophin-associated proteins together with nicotinic acetylcholine receptors by denervation in the absence of dystrophin in skeletal muscles of mdx mice. , 1996, Biochemical and biophysical research communications.
[206] J. Lefaucheur,et al. Factors inducing mast cell accumulation in skeletal muscle , 1996, Neuropathology and applied neurobiology.
[207] H. Kaminski,et al. Nitric oxide synthase is concentrated at the skeletal muscle endplate , 1996, Brain Research.
[208] I. Nonaka,et al. QUANTITATIVE ANALYSIS OF DYSTROPHIN IN HUMAN AND RODENT MUSCLES , 1992 .
[209] R. Hodges,et al. The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle , 1988, Nature.
[210] K. Campbell,et al. Identification and Characterization of the Dystrophin Anchoring Site on β-Dystroglycan (*) , 1995, The Journal of Biological Chemistry.
[211] R. Strohman,et al. Satellite cells from dystrophic (mdx) mouse muscle are stimulated by fibroblast growth factor in vitro. , 1988, Differentiation; research in biological diversity.
[212] S. Goodman,et al. Laminin alters cell shape and stimulates motility and proliferation of murine skeletal myoblasts. , 1988, Developmental biology.
[213] K. Davies,et al. Utrophin: A potential replacement for dystrophin? , 1993, Neuromuscular Disorders.
[214] G. Dickson,et al. Gene therapy for Duchenne muscular dystrophy , 2012 .
[215] M. Fiszman,et al. Inhibition of proliferation in 8-week-old mdx mouse muscle fibroblasts in vitro. , 1995, Differentiation; research in biological diversity.
[216] A. Fassati,et al. Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells. , 1997, The Journal of clinical investigation.
[217] R. Rosenfeld,et al. Insulin-like growth factors (IGFs) reduce IGF-binding protein-4 (IGFBP-4) concentration and stimulate IGFBP-3 independently of IGF receptors in human fibroblasts and epidermal cells. , 1992, Endocrinology.
[218] K. Campbell,et al. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity , 1993, Nature.
[219] L. Kunkel,et al. Feline muscular dystrophy with dystrophin deficiency. , 1989, The American journal of pathology.
[220] Law Dj,et al. Dystrophin deficiency is associated with myotendinous junction defects in prenecrotic and fully regenerated skeletal muscle. , 1993 .
[221] J. Lansman,et al. Calcium entry through stretch-inactivated ion channels in mdx myotubes , 1990, Nature.
[222] R. Sklar,et al. Defective dystrophin in Duchenne and Becker dystrophy myotubes in cell culture , 1990, Neurology.
[223] J. E. Anderson,et al. Anabolic steroid treatment increases myofiber damage in mdx mouse muscular dystrophy , 1994, Journal of the Neurological Sciences.
[224] C. Slater,et al. Structure and function of the neuromuscular junction in young adultmdx mice , 1991, Journal of neurocytology.
[225] O. Ibraghimov-Beskrovnaya,et al. Primary structure and muscle-specific expression of the 50-kDa dystrophin-associated glycoprotein (adhalin). , 1993, The Journal of biological chemistry.
[226] R. Edwards,et al. Effects of calcium on protein turnover of incubated muscles from mdx mice. , 1991, The American journal of physiology.
[227] Y. Kaneda,et al. Expression of full-length human dystrophin cDNA in mdx mouse muscle by HVJ-liposome injection. , 1996, Gene therapy.
[228] L. Kunkel,et al. Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. , 1990, The Journal of biological chemistry.
[229] Simon C Watkins,et al. The basal lamina is a physical barrier to herpes simplex virus-mediated gene delivery to mature muscle fibers , 1996, Journal of virology.
[230] J. Caldwell,et al. Interaction of Muscle and Brain Sodium Channels with Multiple Members of the Syntrophin Family of Dystrophin-Associated Proteins , 1998, The Journal of Neuroscience.
[231] T. Miike,et al. Developmental studies of dystrophin-positive fibers in mdx, and DRP localization , 1993, Journal of the Neurological Sciences.
[232] J. Ervasti,et al. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin , 1993, The Journal of cell biology.
[233] M. Peschanski,et al. Targeting widespread sites of damage in dystrophic muscle: engrafted macrophages as potential shuttles. , 1996, Gene Therapy.
[234] J. Hugnot,et al. Expression of the dystrophin gene in cultured fibroblasts. , 1993, Biochemical and biophysical research communications.
[235] George Karpati,et al. Myoblast transfer in duchenne muscular dystrophy , 1993, Annals of neurology.
[236] M. Butler,et al. Localization of dystrophin relative to acetylcholine receptor domains in electric tissue and adult and cultured skeletal muscle , 1991, The Journal of cell biology.
[237] J. Changeux,et al. Asymmetric distribution of dystrophin in developing and adult Torpedo marmorata electrocyte: evidence for its association with the acetylcholine receptor-rich membrane. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[238] Eric P. Hoffman,et al. The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs , 1988, Nature.
[239] L. Kunkel,et al. Dystrophin abnormalities in Duchenne/Becker muscular dystrophy , 1989, Neuron.
[240] J. Bouchard,et al. Human myoblast transplantation: Preliminary results of 4 cases , 1992, Muscle & nerve.
[241] Simon C Watkins,et al. The subcellular distribution of dystrophin in mouse skeletal, cardiac, and smooth muscle , 1991, The Journal of cell biology.
[242] R. Cross,et al. Structural predictions for the central domain of dystrophin , 1990, FEBS letters.
[243] B. Bressler,et al. Extracts from MDX and normal mouse skeletal muscle contain similar levels of mitogenic activity for myoblasts , 1994, Cell biology international.
[244] K. Campbell,et al. mdx muscle pathology is independent of nNOS perturbation. , 1998, Human molecular genetics.
[245] S. Noguchi,et al. Dystrophin-associated proteins in muscular dystrophy. , 1995, Human molecular genetics.
[246] E. Chihara,et al. Axonal transport in mdx mouse sciatic nerve , 1989, Journal of the Neurological Sciences.
[247] M. Jullien,et al. Diffusible factor(s) controlling density inhibition of 3T3 cell growth: A new approach , 1978, Journal of cellular physiology.
[248] G. Kannourakis,et al. Leukemia inhibitory factor and interleukin‐6 are produced by diseased and regenerating skeletal muscle , 1996, Muscle & nerve.
[249] K. Davies,et al. Postsynaptic Abnormalities at the Neuromuscular Junctions of Utrophin-deficient Mice , 1997, The Journal of cell biology.
[250] M. F. Peters,et al. Isoform Diversity of Dystrobrevin, the Murine 87-kDa Postsynaptic Protein (*) , 1996, The Journal of Biological Chemistry.
[251] G. Radda,et al. Brain metabolism is abnormal in the mdx model of Duchenne muscular dystrophy. , 1996, Brain : a journal of neurology.
[252] Hanns Lochmüller,et al. Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice , 1998, Gene Therapy.
[253] J. Sanes,et al. Skeletal and Cardiac Myopathies in Mice Lacking Utrophin and Dystrophin: A Model for Duchenne Muscular Dystrophy , 1997, Cell.
[254] Z. Hall,et al. Dystroglycan binds nerve and muscle agrin , 1994, Neuron.
[255] H. Blau,et al. Myoblast implantation in Duchenne muscular dystrophy: The San Francisco study , 1997, Muscle & nerve.
[256] J. Tidball,et al. Calpains Are Activated in Necrotic Fibers from mdx Dystrophic Mice (*) , 1995, The Journal of Biological Chemistry.
[257] G. Radda,et al. An in vivo and in vitro 1H-magnetic resonance spectroscopy study of mdx mouse brain: Abnormal development or neural necrosis? , 1996, Journal of the Neurological Sciences.
[258] D. Hill,et al. An autosomal transcript in skeletal muscle with homology to dystrophin , 1989, Nature.
[259] Simon C Watkins,et al. Detection of a specific isoform of alpha-actinin with antisera directed against dystrophin , 1989, The Journal of cell biology.
[260] F. Bezanilla,et al. Sodium current and membrane potential in EDL muscle fibers from normal and dystrophic (mdx) mice. , 1991, The American journal of physiology.
[261] K. Campbell,et al. Dystrophin–glycoprotein complex: Its role in the molecular pathogenesis of muscular dystrophies , 1994, Muscle & nerve.
[262] M. Grounds,et al. Quantitation of muscle precursor cell activity in skeletal muscle by Northern analysis of MyoD and myogenin expression: Application to dystrophic (mdx) mouse muscle , 1992, Molecular and Cellular Neuroscience.
[263] J. Stull,et al. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[264] M. J. Dauncey,et al. Ouabain sensitive Na+ K+-ATPase content is elevated in mdx mice: Implications for the regulation of ions in dystrophic muscle , 1995, Journal of the Neurological Sciences.
[265] U. Francke,et al. Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization. , 1993, Human molecular genetics.
[266] R. Sealock,et al. Dystrophin as a focal adhesion protein , 1990, FEBS letters.
[267] L. S. Quinn,et al. Paracrine control of myoblast proliferation and differentiation by fibroblasts. , 1990, Developmental biology.
[268] Susan C. Brown,et al. Utrophin-Dystrophin-Deficient Mice as a Model for Duchenne Muscular Dystrophy , 1997, Cell.
[269] J. Faulkner,et al. Contractile properties of diaphragm muscle segments from old mdx and old transgenic mdx mice. , 1997, The American journal of physiology.
[270] A. Macieira-Coelho,et al. Growth inhibitory activity in extracts from human fibroblasts , 1993, Journal of cellular physiology.
[271] A. Gramolini,et al. Muscle and Neural Isoforms of Agrin Increase Utrophin Expression in Cultured Myotubes via a Transcriptional Regulatory Mechanism* , 1998, The Journal of Biological Chemistry.
[272] K M Brière,et al. Nuclear magnetic resonance spectroscopy study of muscle growth, mdx dystrophy and glucocorticoid treatments: correlation with repair , 1998, NMR in biomedicine.
[273] L. Metzinger,et al. Regulation of cytosolic calcium in skeletal muscle cells of the mdx mouse under conditions of stress , 1996, British journal of pharmacology.
[274] S. Yamada,et al. Fibroblast growth factor in the extracellular matrix of dystrophic (mdx) mouse muscle. , 1989, Science.
[275] J. Shrager,et al. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy , 1991, Nature.
[276] B. Allard,et al. Similarity of ATP‐dependent K+ channels in skeletal muscle fibres from normal and mutant mdx mice. , 1997, The Journal of physiology.
[277] C. Caskey,et al. Expression and Localization of Dystrophin in Human Cardiac Purkinje Fibers , 1992, Circulation.
[278] H. Ishikawa,et al. Confocal laser microscopy of dystrophin localization in guinea pig skeletal muscle fibers , 1992, The Journal of cell biology.
[279] Jeffrey D. Esko,et al. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.
[280] S. Hirai,et al. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects , 1993, Journal of the Neurological Sciences.
[281] J. Léger,et al. Direct visualization of the dystrophin network on skeletal muscle fiber membrane , 1992, The Journal of cell biology.
[282] A. Kämper,et al. Alterations of protein degradation and 2-D protein pattern in muscle cells of MDX and DMD origin. , 1992, Biochemical and biophysical research communications.
[283] J. Sanes,et al. Synaptic Integrins in Developing, Adult, and Mutant Muscle: Selective Association of α1, α7A, and α7B Integrins with the Neuromuscular Junction , 1996 .
[284] M. Freemark,et al. Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulating IGF-binding protein-4 in dermal fibroblasts. , 1992, Endocrinology.
[285] H. Blau,et al. Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: Implications for cell and gene therapy , 1990, Somatic cell and molecular genetics.
[286] J. E. Anderson,et al. Analysis of dystrophin in fast‐ and slow‐twitch skeletal muscles from mdx and dy2J mice at different ages , 1990, Muscle & nerve.
[287] K. Davies,et al. Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice , 1997, Nature Medicine.
[288] C. Huard,et al. Prevention by anti-LFA-1 of acute myoblast death following transplantation. , 1997, Journal of immunology.
[289] M. Passos-Bueno,et al. Absence of correlation between utrophin localization and quantity and the clinical severity in Duchenne/Becker dystrophies. , 1995, American journal of medical genetics.
[290] J. Merlie,et al. Assembly of the postsynaptic apparatus , 1995, Current Opinion in Neurobiology.
[291] J. Tidball,et al. Talin, vinculin and DRP (utrophin) concentrations are increased at mdx myotendinous junctions following onset of necrosis. , 1994, Journal of cell science.
[292] S. Goldstein,et al. Insulin-like growth factor binding protein 3 accumulates to high levels in culture medium of senescent and quiescent human fibroblasts. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[293] K. Campbell,et al. A role for dystrophin-associated glycoproteins and utrophin in agrin-induced AChR clustering , 1994, Cell.
[294] D. Figarella-Branger,et al. Expression of NCAM and its polysialylated isoforms during mdx mouse muscle regeneration and in vitro myogenesis , 1994, Neuromuscular Disorders.
[295] D. Wells,et al. Age-related changes in collagen gene expression in the muscles of mdx dystrophic and normal mice , 1994, Neuromuscular Disorders.
[296] G. Porter,et al. Dystrophin Colocalizes with -spectrin in Distinct Subsarcolemmal Domains in Mammalian Skeletal Muscle , 1992 .
[297] A. Clerk,et al. Characterisation of dystrophin during development of human skeletal muscle. , 1992, Development.
[298] D. Stephenson,et al. Ca2+ levels in myotubes grown from the skeletal muscle of dystrophic (mdx) and normal mice. , 1993, The Journal of physiology.
[299] H. Blau,et al. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation , 1992, Nature.
[300] C. Young,et al. Different distributions of dystrophin and related proteins at nerve-muscle junctions. , 1992, Neuroreport.